Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 5 studies | 24% ± 6% | |
| GABAergic neuron | 4 studies | 32% ± 17% | |
| epithelial cell | 3 studies | 28% ± 7% | |
| glutamatergic neuron | 3 studies | 39% ± 13% | |
| type I pneumocyte | 3 studies | 17% ± 1% | |
| macrophage | 3 studies | 19% ± 2% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| interneuron | 3 studies | 42% ± 17% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 33% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 614.06 | 653 / 653 | 100% | 19.65 | 603 / 605 |
| brain | 100% | 522.62 | 2631 / 2642 | 100% | 16.25 | 705 / 705 |
| kidney | 100% | 788.35 | 89 / 89 | 100% | 18.56 | 897 / 901 |
| ovary | 100% | 623.96 | 180 / 180 | 100% | 15.34 | 428 / 430 |
| breast | 100% | 552.85 | 459 / 459 | 99% | 17.87 | 1111 / 1118 |
| uterus | 100% | 566.50 | 170 / 170 | 99% | 24.68 | 454 / 459 |
| intestine | 100% | 826.73 | 966 / 966 | 99% | 27.46 | 521 / 527 |
| prostate | 100% | 585.40 | 245 / 245 | 99% | 11.19 | 496 / 502 |
| skin | 99% | 682.23 | 1794 / 1809 | 99% | 19.90 | 466 / 472 |
| bladder | 100% | 725.00 | 21 / 21 | 98% | 22.03 | 493 / 504 |
| stomach | 99% | 824.38 | 357 / 359 | 98% | 24.67 | 280 / 286 |
| lung | 99% | 709.80 | 570 / 578 | 99% | 20.18 | 1138 / 1155 |
| pancreas | 98% | 386.27 | 320 / 328 | 98% | 17.28 | 174 / 178 |
| esophagus | 100% | 622.76 | 1443 / 1445 | 95% | 14.94 | 173 / 183 |
| adrenal gland | 100% | 661.55 | 258 / 258 | 94% | 13.09 | 216 / 230 |
| liver | 100% | 433.27 | 225 / 226 | 92% | 11.92 | 374 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 12.29 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 28.28 | 29 / 29 |
| muscle | 100% | 1568.10 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 847.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.03 | 1 / 1 |
| adipose | 100% | 555.24 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 479.01 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 13.21 | 44 / 45 |
| heart | 97% | 767.76 | 836 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 973.02 | 759 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008150 | Biological process | biological_process |
| GO_0009117 | Biological process | nucleotide metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0016791 | Molecular function | phosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003674 | Molecular function | molecular_function |
| GO_1990738 | Molecular function | pseudouridine 5'-phosphatase activity |
| Gene name | PUDP |
| Protein name | Pseudouridine 5'-phosphatase Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase) |
| Synonyms | GS1 HDHD1A FAM16AX DXF68S1E HDHD1 |
| Description | FUNCTION: Dephosphorylates pseudouridine 5'-phosphate, a potential intermediate in rRNA degradation. Pseudouridine is then excreted intact in urine. . |
| Accessions | ENST00000424830.6 [Q08623-4] ENST00000412827.6 [Q08623-2] ENST00000381077.10 [Q08623-1] Q08623 ENST00000655425.1 A0A590UJH7 ENST00000486446.3 [Q08623-3] |
